+Search query
-Structure paper
| Title | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. |
|---|---|
| Journal, issue, pages | Nat Microbiol, Year 2026 |
| Publish date | Mar 12, 2026 |
Authors | Seth J Zost / Naveenchandra Suryadevara / Lauren E Williamson / Suzanne M Scheaffer / Elad Binshtein / Cameron D Buchman / Nicole V Johnson / Nicholas J Catanzaro / Silvia Ravera / Nathaniel S Chapman / Luke Myers / Ajit R Ramamohan / Laura S Handal / Doan C Nguyen / Andrew Trivette / James R Martinez / Eduardo Villalobos / Stacey A Rutherford / F Eun-Hyung Lee / Alexandra Schäfer / Ralph S Baric / Jason S McLellan / Michael S Diamond / Robert H Carnahan / James E Crowe / ![]() |
| PubMed Abstract | The emergence of SARS-CoV-2 Omicron variants has led to viral escape from many clinically approved monoclonal antibodies (mAbs) due to rapid evolution of the receptor-binding domain (RBD). Co- ...The emergence of SARS-CoV-2 Omicron variants has led to viral escape from many clinically approved monoclonal antibodies (mAbs) due to rapid evolution of the receptor-binding domain (RBD). Co-circulation of SARS-CoV-2 variants with unique sets of antigenic substitutions has further complicated therapeutic mAb discovery. New approaches are needed to rapidly discover and characterize mAbs with preferred specificity and functional characteristics. Here we describe and perform epitope-focused mAb discovery using glycan-masked antigens. We isolated and expressed a panel of 303 mAbs, some of which potently neutralize divergent Omicron subvariants by targeting the class 3 antigenic site on SARS-CoV-2 RBD. Epitope mapping of these antibodies revealed a spectrum of cross-reactivity and differential recognition of the class 3 site, validating the utility of this enrichment approach for targeted mAb discovery. Together, this work rationally designs glycan-masked engineered RBDs and uses them to isolate mAbs that potently neutralize antigenically divergent SARS-CoV-2 variants. |
External links | Nat Microbiol / PubMed:41820555 |
| Methods | EM (single particle) / X-ray diffraction |
| Resolution | 2.68 - 28.0 Å |
| Structure data | ![]() EMDB-43882: Negative stain EM map of SARS-COV-2 (XBB) spike protein in complex with Fab COV2-3872 ![]() EMDB-43883: Negative stain EM map of SARS-COV-2 (XBB) spike protein in complex with Fab COV2-3889 ![]() EMDB-43884: Negative stain EM map of SARS-COV-2 (BQ 1.1) spike protein in complex with Fab COV2-3891 ![]() EMDB-43885: Negative stain EM map of SARS-COV-2 (XBB) spike protein in complex with Fab COV2-3892 ![]() EMDB-43886: Negative stain EM map of SARS-COV-2 (XBB) spike protein in complex with Fab COV2-3906 ![]() EMDB-43887: Negative stain EM map of SARS-COV-2 (XBB) spike protein in complex with Fab COV2-3967 ![]() EMDB-43888: Negative stain EM map of SARS-COV-2 (XBB) spike protein in complex with Fab COV2-4094 ![]() PDB-9c6y: |
| Chemicals | ![]() ChemComp-SO4: ![]() ChemComp-CL: ![]() ChemComp-NAG: ![]() ChemComp-A2G: ![]() ChemComp-HOH: |
| Source |
|
Keywords | VIRAL PROTEIN/IMMUNE SYSTEM / coronavirus / antibody / fab / IMMUNE SYSTEM / VIRAL PROTEIN-IMMUNE SYSTEM complex |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links













homo sapiens (human)
Keywords